abstention from CIN2 treatment and surveillance for at least 2 years clinical trials

Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN

This study looks at whether regular checks instead of immediate treatment can be safe for women aged 18-39 with a mild cell change called CIN2. It aims to see if CIN2 can clear up on its own over two years, avoiding surgery and its potential downsides.